@article{c38eb4e59d43485a860aaf12b2fce9df,
title = "Systematic review of preservation TMS that includes continuation, maintenance, relapse-prevention, and rescue TMS",
abstract = "Background: A dearth of evidence-based information exists to guide the delivery of transcranial magnetic stimulation (TMS) after a successful acute course of treatment for Major Depressive Disorder. Methods: To provide guidance for clinicians, existing literature focused on “preservation TMS” was systematically reviewed and synthesized. Preservation TMS was defined as TMS used to sustain a clinical response after a successful acute course of treatment and included reports using the terms maintenance, continuation, relapse prevention, or rescue TMS. The review protocol was registered on Open Science Framework and reported following PRISMA guidelines. Data were abstracted by two authors and discrepancies were resolved by a third author. Primary outcome measures focused on clinical efficacy. The evaluated studies were graded using the Levels of Evidence criteria published by the Oxford Centre for Evidence-Based Medicine. Results: The search included 536 abstracts and 16 additional papers, from which 63 full articles were screened. Data were abstracted from 30 qualifying sources (N=1,494) including 4 randomized controlled trials (one sham controlled), 14 open trials, and 12 case series. Overall, the quality of existing literature was low regarding efficacy but provided clear support for effectiveness and safety across a range of preservation TMS protocols based on mostly uncontrolled studies. Conclusions: Existing literature suggests that preservation TMS protocols significantly vary and are mostly supported by open trials and case series. Due to a lack of effective alternatives, preservation TMS will likely be required for certain patients who respond to acute TMS therapy. More studies of preservation TMS are critically needed.",
keywords = "Continuation, Depression, Maintenance, Reintroduction, Preservation TMS, and Rescue, Relapse-prevention, TMS, Transcranial magnetic stimulation",
author = "Saydra Wilson and Croarkin, {Paul E.} and Aaronson, {Scott T.} and Carpenter, {Linda L.} and Michelle Cochran and Stultz, {Debra J.} and {Andrew Kozel}, F.",
note = "Funding Information: Saydra Wilson reports no relevant disclosures. Paul E. Croarkin has received research support from the National Institute of Mental Health, Neuronetics, NeoSync, MagVenture, and Pfizer. He has received material support from and provided consultation to Myraid Neuroscience. He has consulted for Engrail Therapeutics, Procter & Gamble Company, and Sunovion. Scott T. Aaronson has received research support from Neuronetics and Compass Pathways. He has consulted to Neuronetics, LivaNova, Neurolief, Janssen, Sage Therapeutics and Genomind. Linda Carpenter has received research support from the National Institutes of Health, Neuronetics, Janssen, NeoSync, Nexstim, Neurolief, and AffectNeuro. She has consulted to Janssen, Neuronetics, Nexstim, Neurolief, AffectNeuro, Sage Therapeutics, Sunovion, and Otsuka. Michelle Cochran reports she is the majority shareholder in NeuroScience & TMS Treatment Centers, www.hopeforyourbrain.com . The practice owns three TMS devices. She has been a past paid consultant with Neuronetics and MagStim and is a paid Clinical TMS Society faculty member and Co-chair for the society's introductory education course, PULSES. Dr. Cochran founded and co-authored Train Your Brain: Your Record of Care with TMS, www.TMSworkbook.com . Debra J. Stultz reports no relevant disclosures. F. Andrew Kozel has received research support from the Department of Defense, VA Office of Research Development, and National Institutes of Health. He has been an unpaid consultant to Neuronetics. Funding Information: The authors would like to thank Ms. Leslie Hassett, M.L.S. Outreach Librarian, Mayo Clinic Libraries. We would also like to thank Dr. Kevin Reeves who provided thoughtful review and suggestions for this manuscript. Publisher Copyright: {\textcopyright} 2021 Elsevier B.V.",
year = "2022",
month = jan,
day = "1",
doi = "10.1016/j.jad.2021.09.040",
language = "English (US)",
volume = "296",
pages = "79--88",
journal = "Journal of Affective Disorders",
issn = "0165-0327",
publisher = "Elsevier",
}